We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Snyder's-Lance (LNCE) Looks Good: Stock Adds 12.7% in Session
Read MoreHide Full Article
Snyder's-Lance, Inc. was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 25.7% in the past one-month time frame.
The upside was perhaps driven by reports that the snack food company was approached by Campbell Soup for a potential acquisition bid.
The company has seen no positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has moved higher over the past few months, suggesting that more solid trading could be ahead for Snyder's-Lance. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Snyder's-Lance currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Is LNCE going up? Or down? Predict to see what others think:Up or Down
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
Snyder's-Lance (LNCE) Looks Good: Stock Adds 12.7% in Session
Snyder's-Lance, Inc. was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 25.7% in the past one-month time frame.
The upside was perhaps driven by reports that the snack food company was approached by Campbell Soup for a potential acquisition bid.
The company has seen no positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has moved higher over the past few months, suggesting that more solid trading could be ahead for Snyder's-Lance. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Snyder's-Lance currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Snyder's-Lance, Inc. Price
Snyder's-Lance, Inc. Price | Snyder's-Lance, Inc. Quote
Investors interested in the Food - Miscellaneous industry may consider Greencore Group plc (GNCGY - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is LNCE going up? Or down? Predict to see what others think:Up or Down
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>